AZN

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: ABBV PFE JNJ MRK NVS BMY GSK SNY LLY AMGN

| Held by: QQQ QQQM PVAL CGGO DIHP DFIC FVD AVDE TQQQ PPH

Index	NDX	P/E	29.84	EPS (ttm)	2.67	Insider Own	0.01%	Shs Outstand	3.10B	Perf Week	-2.62%
Market Cap	246.67B	Forward P/E	15.41	EPS next Y	5.16	Insider Trans	0.00%	Shs Float	3.10B	Perf Month	2.08%
Enterprise Value	272.50B	PEG	2.53	EPS next Q	1.15	Inst Own	16.23%	Short Float	0.25%	Perf Quarter	6.08%
Income	8.32B	P/S	4.36	EPS this Y	10.98%	Inst Trans	-1.11%	Short Ratio	1.81	Perf Half Y	3.99%
Sales	56.59B	P/B	5.52	EPS next Y	13.32%	ROA	7.68%	Short Interest	7.77M	Perf YTD	21.43%
Book/sh	14.42	P/C	34.70	EPS next 5Y	11.80%	ROE	19.76%	52W High	82.41 -3.46%	Perf Year	-1.97%
Cash/sh	2.29	P/FCF	21.46	EPS past 3/5Y	285.92% 34.53%	ROIC	11.77%	52W Low	61.24 29.92%	Perf 3Y	33.00%
Dividend Est.	1.62 (2.04%)	EV/EBITDA	14.51	Sales past 3/5Y	12.66% 17.18%	Gross Margin	72.56%	Volatility	1.33% 1.23%	Perf 5Y	48.49%
Dividend TTM	1.56 (1.97%)	EV/Sales	4.82	EPS Y/Y TTM	29.15%	Oper. Margin	21.13%	ATR (14)	1.20	Perf 10Y	146.77%
Dividend Ex-Date	Aug 08, 2025	Quick Ratio	0.67	Sales Y/Y TTM	15.08%	Profit Margin	14.71%	RSI (14)	52.96	Recom	1.43
Dividend Gr. 3/5Y	2.54% 2.10%	Current Ratio	0.86	EPS Q/Q	28.74%	SMA20	-1.13%	Beta	0.38	Target Price	92.81
Payout	66.95%	Debt/Eq	0.73	Sales Q/Q	13.06%	SMA50	5.04%	Rel Volume	1.05	Prev Close	81.10
Employees	94300	LT Debt/Eq	0.58	Earnings	Jul 29 BMO	SMA200	10.91%	Avg Volume	4.29M	Price	79.56
IPO	May 12, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.44% 2.55%	Trades		Volume	4,491,275	Change	-1.90%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-15-25	Initiated	Exane BNP Paribas	Outperform	$75
Feb-13-25	Upgrade	UBS	Neutral → Buy
Feb-12-25	Initiated	Morgan Stanley	Overweight
Nov-20-24	Upgrade	UBS	Sell → Neutral
Nov-06-24	Upgrade	Deutsche Bank	Sell → Hold
Sep-13-24	Downgrade	Deutsche Bank	Hold → Sell
May-30-24	Initiated	Goldman	Buy	$97
Apr-16-24	Upgrade	Deutsche Bank	Sell → Hold
Feb-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jan-23-24	Initiated	Morgan Stanley	Overweight	$85
Jan-16-24	Resumed	UBS	Sell
Jan-03-24	Downgrade	Jefferies	Buy → Hold	$78.50 → $70
Dec-18-23	Initiated	HSBC Securities	Buy	$78
Sep-25-23	Upgrade	Jefferies	Hold → Buy	$66.50 → $80
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-12-23	Upgrade	UBS	Neutral → Buy
Jul-05-23	Downgrade	Deutsche Bank	Buy → Hold
Apr-11-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-05-23	Initiated	BMO Capital Markets	Outperform	$82
Sep-15-22	Downgrade	Credit Suisse	Outperform → Neutral

Show Previous Ratings

Today 05:15AM	3 Emerging Tech Stocks That Could Help Set You Up for Life (Motley Fool)
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
12:11PM	Novartis Catches a Sell. Goldman Sachs Says the Stock Is Overvalued. (Barrons.com)
10:38AM	OLMA Stock Soars 47% in September So Far on Second PFE Deal (Zacks)
10:25AM	Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects (Zacks)
09:08AM	Loading…
09:08AM	Is BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug? (Zacks)
03:42AM	The Zacks Analyst Blog Highlights Oracle, AstraZeneca, Shopify and Blue Ridge Bankshares (Zacks)
01:01AM	AstraZeneca (AZN) Price Target Backed by Goldman After Baxdrostat Phase 3 Data (Insider Monkey)
Sep-11-25 04:16PM	Top Research Reports for Oracle, AstraZeneca & Shopify (Zacks)
06:30AM	Chinas Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington (The Daily Upside)
Sep-10-25 03:55PM	China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order (Investor's Business Daily)
03:05PM	FDA Expands Approval For AstraZeneca's Drug For Pediatric Patients With Rare Type Of Cancer (Benzinga)
11:02AM	J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum (Zacks)
Sep-09-25 11:34AM	LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal (Zacks)
11:21AM	Will LLY's Oncology Portfolio Provide Key Diversification Benefits? (Zacks)
09:45AM	Loading…
09:45AM	Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term (Zacks)
Sep-08-25 04:59PM	Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term (Zacks)
04:06PM	Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again (Investor's Business Daily)
01:44PM	AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study (Benzinga)
Sep-07-25 08:23AM	These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts (Motley Fool)
07:00AM	TAGRISSO (osimertinib) plus chemotherapy demonstrated a median overall survival of nearly four years, the longest benefit ever reported in a global Phase III trial in EGFR-mutated advanced lung cancer (Business Wire)
Sep-06-25 12:58AM	Goldman Sachs Remains Bullish on AstraZeneca (AZN) (Insider Monkey)
Sep-05-25 10:53AM	BDTX Stock Surges 51.1% in Six Months: Is There More Room for Growth? (Zacks)
Sep-04-25 10:46AM	Is the Recent Pipeline Progress on its NSCLC Drug Enough for BDTX? (Zacks)
Sep-03-25 02:20PM	Final Trades: AstraZeneca, Corning, the IBIT and the SPHD (CNBC TV)
11:40AM	IonQ Sets Bold Quantum Goal but High Valuation Makes Investors Wary (Zacks)
10:47AM	IONS Hits 52-Week High on Tryngolza's Success in Lowering Triglyceride (Zacks)
10:07AM	MRK Posts Cholesterol Drug Data, Focus Shifts Back to Its Pipeline (Zacks)
10:04AM	J&J Gears Up for Some Key New Drug Approvals and Launches (Zacks)
06:30AM	Lung Disease Breakthrough Boosts United Therapeutics and its Rivals (The Daily Upside)
06:00PM	Loading…
Sep-02-25 06:00PM	More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off. (Barrons.com)
09:59AM	AstraZeneca's Latest Drug Offers Hope For Millions Battling Hard-To-Control Blood Pressure (Benzinga)
Aug-30-25 10:19AM	Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial (Business Wire)
10:15AM	AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results (Investor's Business Daily)
Aug-28-25 11:13AM	MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate (Zacks)
09:21AM	Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line? (Zacks)
05:00AM	AstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025 (Insider Monkey)
Aug-25-25 03:00PM	Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now? (Zacks)
Aug-22-25 08:43AM	ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth (Zacks)
Aug-21-25 06:55PM	ReAlta Life Sciences Secures European Orphan Drug Status for Graft-vs-Host Disease Treatment (Exec Edge)
Aug-20-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-19-25 11:37AM	MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:33AM	Strategic Partnerships Power Tempus AI's Healthcare Expansion (Zacks)
09:08AM	Pfizer Oncology Drugs Drive Sales in Q2: Will the Trend Continue? (Zacks)
Aug-18-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
07:00AM	FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation (GlobeNewswire)
06:19AM	The Zacks Analyst Blog Highlights D-Wave Quantum, Rigetti Computing, IonQ, AstraZeneca, AWS and NVIDIA (Zacks)
Aug-15-25 05:30PM	Americas first needle-free, at-home flu vaccine is now available (FastCompany)
01:00PM	Quantum Stocks Q2 2025: Are D-Wave, IonQ & Rigetti Funding the Future? (Zacks)
10:00AM	AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs (Zacks)
08:00AM	FLUMIST (Influenza, Vaccine Live, Intranasal), the nations only nasal spray flu vaccine, now available for home delivery (Business Wire)
Aug-13-25 12:55PM	PFE New & Acquired Drugs Back 1H Top-Line Growth: Will the Trend Last? (Zacks)
07:00AM	The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact (PR Newswire)
Aug-11-25 08:21PM	Revna Biosciences and AstraZeneca Increase Access to Lung Cancer Treatment in Ghana (Insider Monkey)
11:14AM	IonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead? (Zacks)
Aug-08-25 03:00PM	IonQ Secures $1.6 Billion to Power Quantum Projects: Is It a Buy Now? (Zacks)
10:47AM	Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season (Zacks)
10:36AM	IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates (Zacks)
Aug-07-25 08:05AM	Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) and adults with generalized myasthenia gravis (gMG) (PR Newswire)
Aug-06-25 02:19PM	Moderna's stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals (MarketWatch)
09:51AM	Amgen's Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly (Zacks)
Aug-05-25 06:40AM	SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes (PR Newswire)
Aug-03-25 10:00AM	Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time (The Wall Street Journal)
Aug-01-25 03:00PM	Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy? (Zacks)
10:37AM	JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results? (Zacks)
09:50AM	Here's Why Astrazeneca (AZN) is a Strong Momentum Stock (Zacks)
07:46AM	Stocks Buckle Under Trump Tariffs; Amazon Slumps: Markets Wrap (Bloomberg)
07:21AM	Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices (The Wall Street Journal)
07:10AM	Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck (The Wall Street Journal)
06:11AM	European stocks tumble, with German stocks hitting month-low and pharmaceutical names under pressure (MarketWatch)
04:49AM	Stocks to Watch Friday: Apple, Amazon, Coinbase, Reddit (The Wall Street Journal)
Jul-31-25 04:16PM	What Trump's Big Pharma CEO letters mean for drug pricing power (Yahoo Finance Video)
10:37AM	Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down (Zacks)
09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
09:10AM	Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook (Zacks)
Jul-30-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
06:40AM	AstraZeneca Just Missed Estimates, but Here's Why Bulls Aren't Worried Yet (Insider Monkey)
Jul-29-25 04:51PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
04:13PM	Why AstraZeneca Stock Was Topping the Market on Tuesday (Motley Fool)
04:00PM	Pharma tariffs would be 'counterproductive,' industry rep. says (Yahoo Finance Video)
12:54PM	AstraZeneca CEO: If you manufacture locally, there's no need to increase prices (CNBC TV)
12:38PM	AstraZeneca CFO talks tariffs & shifting focus to US market (Yahoo Finance Video)
12:10PM	Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed (Zacks)
10:59AM	The Zacks Analyst Blog Highlights Tempus AI, NVIDIA, AstraZeneca and Novo Nordisk (Zacks)
10:11AM	UnitedHealth's mixed Q2, Novo slashes forecast: What to know (Yahoo Finance Video)
09:30AM	Astrazeneca (AZN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:12AM	AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs Outperform (Zacks)
07:54AM	AstraZeneca's Imfinzi gains FDA priority review (Pharmaceutical Business Review)
07:00AM	AstraZeneca results: H1 and Q2 2025 (Business Wire)
04:23AM	AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth (The Wall Street Journal)
01:39AM	AstraZeneca (AZN) Bets Big on U.S. with $50 Billion Manufacturing Expansion (Insider Monkey)
01:30AM	AstraZeneca PLC (AZN) Announced Positive Results for its Phase 3 Trial of Gefurulimab (Insider Monkey)
Jul-28-25 01:30PM	Tempus AI or NVIDIA: Which is the Smarter Bet in AI-Backed Healthcare? (Zacks)
10:28AM	Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts? (Zacks)
07:00AM	IMFINZI (durvalumab) granted Priority Review and Breakthrough Therapy Designation in the US for patients with resectable early-stage gastric and gastroesophageal junction cancers (Business Wire)
Jul-26-25 12:51AM	AstraZeneca's (AZN) Dividend: Resilient, Predictable, and Built on Innovation (Insider Monkey)
Jul-25-25 07:00PM	5 Dividend Stocks to Hold for the Next 20 Years (Motley Fool)
06:15PM	Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors (Zacks)
04:24PM	Top Research Reports for NVIDIA, Netflix & Goldman Sachs (Zacks)

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company's history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Astrazeneca plc ADR

Upgrade your FINVIZ experience